Neptune and BlueOcean Sign Licensing AgreementLicensing Agreement • October 20th, 2014 • Neptune Technologies & Bioressources Inc. • Pharmaceutical preparations
LAVAL, Quebec, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB), announces the signing of an exclusive world-wide, royalty-bearing, non-transferable, License Agreement ("License") with BlueOcean Nutrascience Inc. ("BlueOcean") under Neptune's composition and extraction patents covering the production and sale of marine derived oil products containing phospholipids. The License allows BlueOcean and its shrimp joint venture affiliate to produce and sell shrimp oil products extracted from three species of North Atlantic cold water shrimp (Pandalus borealis, Pandalus montagui, and Pandalus jordani) in the nutraceutical, dietary ingredients, natural health products, functional food and food supplements markets. The medical food, drugs and drug product markets are not included.
